Press release details

Helen of Troy Limited Reports Results For the Second Quarter and First Six Months of Fiscal Year 2014

10/09/13

Second Quarter Diluted EPS of $0.72
Core Net Sales Growth of 11.1% Compared to Second Quarter of Prior Fiscal Year

EL PASO, Texas--(BUSINESS WIRE)--Oct. 9, 2013-- Helen of Troy Limited (NASDAQ, NM:HELE), designer, developer and worldwide marketer of brand-name houseware, healthcare/home environment and personal care consumer products, today reported results for the three and six month periods ended August 31, 2013.

Gerald J. Rubin, Chairman of the Board, Chief Executive Officer and President, commenting on the Company's fiscal year 2014 second quarter results, stated, “We are pleased to report solid performance in the second quarter, highlighted by sales growth across all our operating segments and increased consolidated adjusted EBITDA and net income despite product cost and currency headwinds. The period saw particular strength in our Healthcare/Home Environment segment, which produced a 20.4% increase in revenue benefiting from our refined promotion and marketing strategy and favorable weather conditions in Europe. Innovation in product and design continues to be a positive driver for our Housewares segment leading to increases in shelf space, assortment expansion and new distribution. Finally, our Personal Care segment benefited from a new product distribution arrangement in Europe specific to the current fiscal year and increased sales in our professional appliance business.

In the first week of September 2013, we commenced initial operations at our new 1.3 million square foot distribution facility in Mississippi, on time and within budget, and converted our Healthcare/Home environment segment onto our global ERP system, positioning us well to accommodate anticipated future growth.”

Second Quarter of Fiscal Year 2014 Consolidated Operating Results

Net sales revenue increased 11.1% to a record $319.4 million compared to $287.4 million in the second quarter of fiscal year 2013.
Gross profit margin was 38.6% compared to 40.7% for the same period last year, reflecting the effect of foreign currency exchange rates, product cost increases across all segments and product mix.
Selling, general and administrative expense was 29.1% as a percent of net sales compared to 30.0% for the same period last year, a decrease of 0.9 percentage points. The decrease primarily reflects lower outbound freight and distribution costs, as well as reduced media advertising costs. These expense reductions were partially offset by higher incentive compensation costs and higher cooperative advertising costs.
Operating income was $30.4 million, compared to operating income of $30.8 million in the same period last year.
Net income was $23.3 million, or $0.72 per fully diluted share on 32.3 million weighted average shares outstanding, which compares to net income in the second quarter of fiscal year 2013 of $23.0 million, or $0.72 per fully diluted share on 31.8 million weighted average shares outstanding.
Adjusted EBITDA was $41.8 million compared to $41.1 million in the same period last year.

First Six Months of Fiscal Year 2014 Consolidated Operating Results

Net sales revenue increased 6.2% to a record $623.9 million compared to $587.6 million in the first six months of fiscal year 2013.
Gross profit margin was 39.0% compared to 40.5% for the same period last year, reflecting increased promotional program costs, the effect of foreign currency exchange rates, product cost increases across all segments and product mix.
Selling, general and administrative expense was 28.9% as a percent of net sales compared to 30.0% for the same period last year. The decrease reflects lower outbound freight and distribution costs, reduced media advertising costs and a gain from a litigation settlement. These expense reductions were partially offset by higher incentive compensation costs and higher cooperative advertising costs.
Operating income was $51.0 million, which includes the impact of $12.0 million in non-cash asset impairment charges related to certain trademarks in the Company’s Personal Care segment in the first quarter of fiscal 2014, compared to operating income of $62.0 million in the same period last year.
Net income was $37.7 million, or $1.17 per fully diluted share on 32.2 million weighted average shares outstanding, which compares to net income in the first six months of fiscal year 2013 of $46.4 million, or $1.46 per fully diluted share on 31.8 million weighted average shares outstanding.
Adjusted operating income (operating income without non-cash asset impairment charges) was $63.0 million compared to $62.0 million for the same period last year, an increase of 1.7%.
Adjusted income (net income without non-cash asset impairment charges) was $49.7 million, or $1.54 per fully diluted share, compared to $46.4 million, or $1.46 per fully diluted share, in the first six months of fiscal year 2013. This represents an increase in adjusted income of 7.1% and in adjusted diluted EPS of 5.5%.
Adjusted EBITDA was $86.4 million compared to $82.9 million in the same period last year.

Balance Sheet Highlights

Cash and cash equivalents totaled $10.1 million at August 31, 2013, compared to $21.8 million at August 31, 2012.
Total short and long-term debt declined by $108.4 million to $227.6 million at August 31, 2013, compared to $336.0 million at August 31, 2012.
Accounts receivables turnover was 61.9 days at August 31, 2013, compared to 61.1 days at August 31, 2012.
Inventory was $306.9 million at August 31, 2013, compared to $318.7 million at August 31, 2012.

Fiscal Year 2014 Annual Outlook

For fiscal year 2014, the Company continues to expect net sales revenue in the range of $1.29 billion to $1.32 billion, and GAAP diluted EPS in the range of $3.13 to $3.23, which includes the non-cash asset impairment charges of $0.37 per share recorded in the first quarter of fiscal year 2014. The Company expects adjusted diluted EPS to be in the range of $3.50 to $3.60, which is consistent with the Company’s previous guidance. The earnings guidance reflects the negative impact of the difficult retail environment, a normal cold/cough/flu season, product cost increases across all segments and an increase in non-cash compensation expense for the Company’s CEO. The Company expects capital expenditures for fiscal year 2014 to be in the range of $40 million to $45 million, with approximately $33 million related to the completion of the Company’s new 1.3 million square foot distribution center in Olive Branch, Mississippi.

Conference Call and Webcast

The Company will conduct a teleconference in conjunction with today's earnings release. The teleconference begins at 4:45 pm Eastern Time today, Wednesday, October 9, 2013. Institutional investors and analysts interested in participating in the call are invited to dial (888) 504-7963. The conference call will also be available to interested parties through a live webcast at www.hotus.com. Please visit the website and select the “Investor Relations” link at least 15 minutes prior to the start of the call to register and download any necessary software.

A telephone replay of the call will be available until 11:59 pm Eastern Time on October 16, 2013, by dialing (877) 870-5176 (domestic) or (858) 384-5517 (international) and entering the conference replay number: 3190673. Please note participants must enter the conference identification number in order to access the replay.

About Helen of Troy Limited:

About Helen of Troy Limited: Helen of Troy Limited is a leading global consumer products company offering creative solutions for its customers through a strong portfolio of well-recognized and widely-trusted brands, including: Housewares: OXO®, Good Grips®, Soft Works®, OXO tot® and OXO Steel®; Healthcare/Home Environment: Vicks®, Braun®, Honeywell®, PUR®, Febreze®, Stinger®, Duracraft® and SoftHeat®; and Personal Care: Revlon®, Vidal Sassoon®, Dr. Scholl's®, Pro Beauty Tools®, Sure®, Pert®, Infusium23®, Brut®, Ammens®, Hot Tools®, Bed Head®, Karina®, Ogilvie® and Gold 'N Hot®. The Honeywell® trademark is used under license from Honeywell International Inc. The Vicks®, Braun®, Febreze® and Vidal Sassoon® trademarks are used under license from The Procter & Gamble Company. The Revlon® trademark is used under license from Revlon Consumer Products Corporation. The Bed Head® trademark is used under license from Unilever PLC. The Dr. Scholl's® trademark is used under license from MSD Consumer Care, Inc.

For in-depth information about Helen of Troy, please visit www.hotus.com .

Non-GAAP Financial Measures:

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States of America (“GAAP”). To supplement its presentation, the Company discloses certain financial measures that may be considered non-GAAP financial measures, such as adjusted operating income, adjusted income, adjusted diluted EPS, EBITDA and adjusted EBITDA, which are presented in an accompanying table to this press release along with a reconciliation of these financial measures to their corresponding GAAP based measures presented in the Company’s consolidated condensed statements of income.

Forward Looking Statements:

This press release may contain forward-looking statements, which are subject to change. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any or all of the forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many of these factors will be important in determining the Company's actual future results. Consequently, no forward-looking statement can be guaranteed. Actual future results may vary materially from those expressed or implied in any forward-looking statements. The forward-looking statements are qualified in their entirety by a number of risks that could cause actual results to differ materially from historical or anticipated results. Generally, the words "anticipates", "estimates", "believes", "expects", "plans", "may", "will", "should", "seeks", "project", "predict", "potential", "continue", "intends", and other similar words identify forward-looking statements. The Company cautions readers not to place undue reliance on forward-looking statements. The Company intends its forward-looking statements to speak only as of the time of such statements, and does not undertake to update or revise them as more information becomes available. The forward-looking statements contained in this press release should be read in conjunction with, and are subject to and qualified by, the risks described in the Company's Form 10-K for the year ended February 28, 2013 and in our other filings with the SEC. Investors are urged to refer to the risk factors referred to above for a description of these risks. Such risks include, among others, the departure and recruitment of key personnel, the Company's ability to deliver products to our customers in a timely manner, the Company's geographic concentration of certain U.S. distribution facilities, which increases our exposure to significant shipping disruptions and added shipping and storage costs, difficulties encountered during the transition to the Company’s new distribution facility could interrupt the Company’s logistical systems and cause shipping disruptions, the Company's projections of product demand, sales, net income and earnings per share are highly subjective and our future net sales revenue, net income and earnings per share could vary in a material amount from such projections, expectations regarding acquisitions and the integration of acquired businesses, the Company's relationship with key customers and licensors, the costs of complying with the business demands and requirements of large sophisticated customers, the Company's dependence on foreign sources of supply and foreign manufacturing, the impact of changing costs of raw materials and energy on cost of goods sold and certain operating expenses, circumstances that may contribute to future impairment of goodwill, intangible or other long-lived assets, the risks associated with the use of trademarks licensed from and to third parties, our dependence on the strength of retail economies and vulnerabilities to an economic downturn, the Company's ability to develop and introduce innovative new products to meet changing consumer preferences, disruptions in U.S., European and other international credit markets, exchange rate risks, trade barriers, exchange controls, expropriations, and other risks associated with foreign operations, the Company's debt leverage and the constraints it may impose, the costs, complexity and challenges of upgrading and managing our global information systems, the risks associated with information security breaches, the risks associated with tax audits and related disputes with taxing authorities, potential changes in laws, including tax laws, and the Company's ability to continue to avoid classification as a controlled foreign corporation.


HELEN OF TROY LIMITED AND SUBSIDIARIES Consolidated Condensed Statements of Income and Reconciliation of Non-GAAP Financial Measures – Adjusted Operating Income and Adjusted Income (unaudited) (in thousands, except per share data)

	Three Months Ended August 31,
						2013								2012
	As Reported (GAAP)					Adjustments (1)			Adjusted (non-GAAP)(1)(2)					As Reported (GAAP)

Sales revenue, net	$	319,387		100.0	%	$	-		$	319,387		100.0	%	$	287,411		100.0	%
Cost of goods sold		196,132		61.4	%		-			196,132		61.4	%		170,381		59.3	%
Gross profit		123,255		38.6	%		-			123,255		38.6	%		117,030		40.7	%

Selling, general, and administrative expense		92,899		29.1	%		-			92,899		29.1	%		86,189		30.0	%
Asset impairment charges		-		0.0	%		-			-		0.0	%		-		0.0	%
Operating income		30,356		9.5	%		-			30,356		9.5	%		30,841		10.7	%

Other income (expense):
Nonoperating income, net		56		0.0	%		-			56		0.0	%		31		0.0	%
Interest expense		(2,192	)	-0.7	%		-			(2,192	)	-0.7	%		(3,130	)	-1.1	%
Total other expense		(2,136	)	-0.7	%		-			(2,136	)	-0.7	%		(3,099	)	-1.1	%
Income before income taxes		28,220		8.8	%		-			28,220		8.8	%		27,742		9.7	%

Income tax expense		4,902		1.5	%		-			4,902		1.5	%		4,774		1.7	%
Net income	$	23,318		7.3	%	$	-		$	23,318		7.3	%	$	22,968		8.0	%

Diluted earnings per share	$	0.72				$	-		$	0.72				$	0.72

Weighted average shares of common stock used in computing diluted earnings per share		32,272					32,272			32,272					31,846



	Six Months Ended August 31,
						2013								2012
	As Reported (GAAP)					Adjustments (1)			Adjusted (non-GAAP)(1)(2)					As Reported (GAAP)

Sales revenue, net	$	623,903		100.0	%	$	-		$	623,903		100.0	%	$	587,622		100.0	%
Cost of goods sold		380,484		61.0	%		-			380,484		61.0	%		349,444		59.5	%
Gross profit		243,419		39.0	%		-			243,419		39.0	%		238,178		40.5	%

Selling, general, and administrative expense		180,389		28.9	%		-			180,389		28.9	%		176,189		30.0	%
Asset impairment charges		12,049		1.9	%		(12,049	)		-		0.0	%		-		0.0	%
Operating income		50,981		8.2	%		12,049			63,030		10.1	%		61,989		10.5	%

Other income (expense):
Nonoperating income, net		140		0.0	%		-			140		0.0	%		54		0.0	%
Interest expense		(5,134	)	-0.8	%		-			(5,134	)	-0.8	%		(6,442	)	-1.1	%
Total other expense		(4,994	)	-0.8	%		-			(4,994	)	-0.8	%		(6,388	)	-1.1	%
Income before income taxes		45,987		7.4	%		12,049			58,036		9.3	%		55,601		9.5	%

Income tax expense		8,278		1.3	%		15			8,293		1.3	%		9,161		1.6	%
Net income	$	37,709		6.0	%	$	12,034		$	49,743		8.0	%	$	46,440		7.9	%

Diluted earnings per share	$	1.17				$	0.37		$	1.54				$	1.46

Weighted average shares of common stock used in computing diluted earnings per share		32,226					32,226			32,226					31,843


HELEN OF TROY LIMITED AND SUBSIDIARIES Net Sales Revenue by Segment (unaudited) (in thousands)

	Three Months Ended August 31,								% of Sales Revenue, net
	2013		2012		$ Change		% Change		2013		2012

Sales revenue by segment, net
Housewares	$	70,165	$	64,570	$	5,595	8.7	%	22.0	%	22.5	%
Healthcare / Home Environment		133,044		110,477		22,567	20.4	%	41.7	%	38.4	%
Personal Care		116,178		112,364		3,814	3.4	%	36.4	%	39.1	%
Total sales revenue, net		319,387		287,411		31,976	11.1	%	100.0	%	100.0	%


	Six Months Ended August 31,								% of Sales Revenue, net
	2013		2012		$ Change		% Change		2013		2012

Sales revenue by segment, net
Housewares	$	133,695	$	124,819	$	8,876	7.1	%	21.4	%	21.2	%
Healthcare / Home Environment		258,646		232,887		25,759	11.1	%	41.5	%	39.6	%
Personal Care		231,562		229,916		1,646	0.7	%	37.1	%	39.1	%
Total sales revenue, net		623,903		587,622		36,281	6.2	%	100.0	%	100.0	%


HELEN OF TROY LIMITED AND SUBSIDIARIES
Selected Consolidated Balance Sheet Information
(unaudited)
(in thousands)

		8/31/2013		8/31/2012

	Cash and cash equivalents	$	10,097	$	21,767

	Receivables		231,309		208,284

	Inventory		306,854		318,697

	Total assets, current		587,903		574,149

	Total assets		1,518,171		1,509,062

	Total liabilities, current		360,673		401,088

	Total long-term liabilities		186,775		255,614

	Stockholders' equity		970,723		852,360


SELECTED OTHER DATA Reconciliation of Non-GAAP Financial Measures - EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) and Adjusted EBITDA (unaudited) (in thousands)

	Three Months Ended August 31,				Six Months Ended August 31,
	2013		2012		2013		2012

Net income	$	23,318	$	22,968	$	37,709	$	46,440

Interest expense, net		2,208		3,115		5,128		6,400

Income tax expense		4,902		4,774		8,278		9,161

Depreciation and amortization, excluding amortized interest		7,991		8,695		16,438		17,795

EBITDA (Earnings before interest, taxes, depreciation and amortization) (2)	$	38,419	$	39,552	$	67,553	$	79,796


Adjusted EBITDA:

EBITDA, as calculated above	$	38,419	$	39,552	$	67,553	$	79,796

Add: Non-cash asset impairment charges (1)		-		-		12,049		-
Non-cash share-based compensation (3)		3,419		1,527		6,797		3,129

Adjusted EBITDA (2)	$	41,838	$	41,079	$	86,399	$	82,925


Reconciliation of Fiscal Year 2014 Reported Diluted Earnings Per Share (EPS) to Adjusted Diluted EPS to Exclude Non-Cash Asset Impairment Charges (Unaudited)

	Year-To-Date		Guidance for the		Guidance for the
	Actual Through		Balance of the		Fiscal Year Ended
	August 31, 2013		Fiscal Year		February 28, 2013
	(Six Months)		(Six Months)		(Twelve Months)

Diluted EPS, as reported (GAAP)	$	1.17	$	1.96 - $ 2.06	$	3.13 - $ 3.23

Non-cash asset impairment Charges (1)		0.37		-		0.37

Adjusted Diluted EPS (non-GAAP) (2)	$	1.54	$	1.96 - $ 2.06	$	3.50 - $ 3.60


HELEN OF TROY LIMITED AND SUBSIDIARIES
Notes to Press Release
(1)		Adjustments relate to items that are excluded from the “As Reported (GAAP)” results to arrive at the “Adjusted (non-GAAP)” results. Adjustments consist of non-cash asset impairment charges of $12.05 million ($12.03 million after tax) for the six months ended August 31, 2013 as a result of our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2014. The non-cash charges relate to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method. There were no comparable adjustments for the three months ended August 31, 2013, or for the three- and six-months ended August 31, 2012.

(2)		This press release contains non-GAAP financial measures. Adjusted operating income, adjusted income, adjusted diluted EPS, EBITDA and adjusted EBITDA (“Non-GAAP measures”) that are discussed in the accompanying press release or in the preceding tables are considered non-GAAP financial information as contemplated by SEC Regulation G, Rule 100. Accordingly, we are providing the preceding tables that reconcile these measures to their corresponding GAAP based measures presented in our Consolidated Condensed Statements of Income in the accompanying tables to the press release. The Company believes that these non-GAAP measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. The Company believes that these non-GAAP measures, in combination with the Company's financial results calculated in accordance with GAAP, provides investors with additional perspective. The Company further believes that the items excluded from certain non-GAAP measures do not accurately reflect the underlying performance of its continuing operations for the period in which they are incurred, even though some of these excluded items may be incurred and reflected in the Company's GAAP financial results in the foreseeable future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of the Company's activities. These non-GAAP measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial information, and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information.

(3)		Adjustment consists of non-cash share-based compensation expense associated with share based awards outstanding under two expired and three active share-based compensation plans. These awards consist of stock options granted to certain officers, employees and new hires, restricted stock grants to certain members of the Company’s Board of Directors and performance based restricted stock awards and units granted to our Chief Executive Officer under the terms of his employment agreement.

Source: Helen of Troy Limited

Helen of Troy Limited
John Boomer, 915-225-8050
Senior Vice President
or
Investors:
ICR, Inc.
Allison Malkin / Anne Rakunas
203-682-8200 / 310-954-1113

Categories: Press Releases

View all news



Enter the code shown above.
*